Brian Wolpin tells the #STATSummit audience that he believes pancreatic cancer treatment will be transformed by RAS inhibitors: “It's always therapeutically been in the context of, ‘Well, we have to give people chemotherapy, so what do you add to that?’ I think that goes out the window.”